- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Crystal S. Denlinger Calls for Personalized Care in Cancer Survivorship
As innovations in cancer care transform the disease into a chronic illness, the survivorship population encompasses more than early stage patients but survivors of long term metastatic disease as well, explains Crystal S. Denlinger, MD, Fox Chase Cancer Center in Philadelphia.
As innovations in cancer care transform the disease into a chronic illness, Crystal S. Denlinger, MD, Fox Chase Cancer Center in Philadelphia, says that the survivorship population encompasses more than early stage patients but survivors of long term metastatic disease as well.
Many of the challenges that Dr Denlinger says comes along with cancer survivorship is helping the patient come to terms with the new lifestyle changes that treatment and therapy causes. She adds that patients in different stages of survivorship require different care methods.
“Survivorship care has to be broad enough and as providers, we have to be willing to provide care across those three components of care but with different focuses depending on what stage of disease or what component of survivorship an individual person is living in,”Dr Denlinger says.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
